SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to face intense community backlash and skepticism, with investors frequently labeling it a "pump-and-dump" scam that has experienced a near-total loss of value since its launch. Discussion forums are dominated by users venting frustration over significant financial losses, questioning the legitimacy of the project's developers, and drawing parallels between this asset and other controversial Trump-family-backed ventures.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is currently under intense scrutiny following a federal lawsuit against BNY Mellon and others, alleging a scheme that misappropriated DVLT shares as collateral to trigger forced liquidations. Investors are actively debating the potential for a massive supply shock if the court orders a share freeze, while simultaneously voicing significant frustration over the lack of transparency regarding financial reporting and the company's complex, interlinked strategic investments.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is seeing increased investor scrutiny as the market evaluates the airline's latest share buyback program and its ability to improve financial performance amid fluctuating fuel costs and competitive industry conditions. Community sentiment remains polarized, with some traders optimistic about long-term potential following recent NCIB authorization, while others express frustration over extended periods of price stagnation and call for leadership changes.

The Bank of Nova Scotia engages in the provision of financial products and services including personal, commercial, corporate, and investment banking. It operates through the following segments: Canadian Banking, International Banking, Global Wealth Management, Global Banking and Markets, and Other. The company was founded on March 30, 1832 and is headquartered in Toronto, Canada.

Bank Of Nova Scotia

Bank of Nova Scotia is experiencing significant investor activity driven by its recent strategic equity investment in KeyCorp and a focus on expanding its North American footprint. Market participants are actively discussing the bank's valuation, potential growth catalysts, and dividend sustainability amid shifting interest rate expectations.

"What's Updog?" is a Community Led token.

UpDog

The $UPDOG community is actively rallying around the meme coin's long-standing presence on the Solana network, leveraging humorous "dad joke" engagement and persistent social media posting to maintain visibility. Supporters frequently highlight the project's longevity and commitment to retail-driven growth as they continue to promote the ticker across various platforms.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending as investors digest the recent $65M public offering and the signing of a major GPU-as-a-Service contract with Hydra Host. The community is actively debating the potential for an M&A or joint venture with TSSI to scale edge AI infrastructure, alongside bullish sentiment surrounding the company's modular data center strategy and new leadership's ability to drive rapid deal flow.

Axelar delivers secure interchain communication. That means dApp users can interact with any asset, any application, on any chain, with one click. You can think of it as Stripe for Web3. Developers interact with a simple API atop a permissionless network that routes messages and ensures network security via proof-of-stake consensus.  Axelar is a blockchain that connects blockchains. To do this securely, Axelar network uses proof-of-stake consensus. Network validators produce new blocks, participate in multiparty signing and vote on external chain states. Tokenholders stake the AXL token, delegating tokens to a validator’s staking pool and receiving rewards, minus the validator’s commission.  The AXL token is used for governance and to pay network transaction fees to validators and tokenholders. However, users of the Axelar network do not need to hold the token. Conversions into AXL tokens and destination-chain tokens are handled on the back end, so that users need only pay gas once, in the source-chain token.  Axelar network rewards are “inflationary” — they increase the total supply of AXL — but there is potential for supply to become deflationary based on the transaction fee mechanic described above.

Axelar

Axelar is drawing significant investor interest as the market closely monitors its role in cross-chain interoperability, specifically regarding its integration with major projects like the XRP Ledger and stablecoin infrastructure. Community sentiment remains polarized, with many users actively discussing the balance between long-term technological potential and short-term volatility following recent development updates and team transitions.

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Keros Therapeutics Inc

Keros Therapeutics is seeing intense market activity following a significant price decline triggered by the voluntary halt of a Phase 2 trial for its pulmonary arterial hypertension candidate due to safety concerns. While the company maintains a robust cash position and ongoing pipeline development, the community remains divided between investors viewing the sell-off as a severe overreaction to a non-lead asset and those concerned about the company's long-term clinical execution.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as investors debate the potential of agentic AI integration following significant volatility tied to the ASI alliance and token-related FUD. The community remains divided, with many aggressively accumulating at current price levels due to belief in the project's long-term utility, while others express frustration over recent market performance and ongoing macro uncertainty.

BWX Technologies, Inc. engages in the supply and provision of nuclear components and products. It operates through the Government Operations and Commercial Operations segments. The Government Operations segment manufactures naval nuclear reactors, including the related nuclear fuel, for the U.S. Naval Nuclear Propulsion Program for use in submarines and aircraft carriers. The Commercial Operations segment fabricates commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level waste and supplies nuclear-grade materials and precisely machined components for nuclear utility customers. The company was founded by Stephen Wilcox and George Babcock in 1867 and is headquartered in Lynchburg, VA.

BWX Technologies Inc

BWX Technologies is capturing investor interest as a critical infrastructure backbone for U.S. naval nuclear propulsion and a primary supplier for the burgeoning small modular reactor (SMR) sector. The community is actively discussing the stock's role in the global nuclear energy renaissance, often framing it as a 'picks and shovels' play on the industry's long-term pivot toward advanced nuclear power for defense, space exploration, and AI data center energy needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Pharmaceutical Stocks To Watch Today - March 14th

Eli Lilly and Company, AbbVie, Abbott Laboratories, Pfizer, Gilead Sciences, Bristol Myers Squibb, and Vertex Pharmaceuticals are the seven Pharmaceutical stocks to watch today, according to...

Medical Stocks To Consider - March 14th

Eli Lilly and Company, Johnson & Johnson, Thermo Fisher Scientific, UnitedHealth Group, AbbVie, Intuitive Surgical, and Hims & Hers Health are the seven Medical stocks to watch today, according to...

von Borstel & Associates Inc. Takes Position in AbbVie Inc. $ABBV

von Borstel & Associates Inc. purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The...

AbbVie Inc. $ABBV Shares Bought by Zuckerman Investment Group LLC

Zuckerman Investment Group LLC grew its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 7.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities...

NorthRock Partners LLC Has $19.23 Million Stock Position in AbbVie Inc. $ABBV

NorthRock Partners LLC increased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and...

AbbVie Inc. $ABBV Stock Position Decreased by Prudential PLC

Prudential PLC cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 9.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission...

Temasek Holdings Private Ltd Purchases 25,496 Shares of AbbVie Inc. $ABBV

Temasek Holdings Private Ltd boosted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 60.0% in the third quarter, according to the company in its most recent disclosure with the...

Regal Investment Advisors LLC Cuts Position in AbbVie Inc. $ABBV

Regal Investment Advisors LLC lowered its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 9.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm...

Comerica Bank Has $181.67 Million Stock Position in AbbVie Inc. $ABBV

Comerica Bank lowered its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Glenmede Investment Management LP Has $78.78 Million Stock Holdings in AbbVie Inc. $ABBV

Glenmede Investment Management LP trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$3.01	--	--	N/A
Q4 '25	$2.65	$2.71	2.15%	BEAT
Q3 '25	$1.77	$1.86	5.32%	BEAT
Q2 '25	$2.88	$2.97	3.12%	BEAT
Q1 '25	$2.38	$2.46	3.39%	BEAT

ABBV
Abbvie Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ABBV News

ABBVAbbvie Inc